All News

Ryan Bosch, MD, FACP, founder and president of Socially Determined, outlines steps for improving health literacy.

The study portrays the intense need for daily care experienced by children with aromatic L-Amino acid decarboxylase deficiency (AADC-d) and their families.

The exploration of the MAPK pathway has come as researchers look for new therapeutic targets for acute myeloid leukemia (AML), which still faces resistance to novel treatments like FLT3 inhibitors and subsequent relapses.

Humana's Bold Goal program allowed the health care giant to test new delivery models that it used to address loneliness and food insecurity during COVID-19.

The increase in hospitalization risk seen with Vascepa was small vs the survival gains seen from decreased rates of heart attack, stroke, and revascularization, noted Deepak L. Bhatt, MD, MPH, Brigham and Women’s Hospital Heart & Vascular Center.

A reported association between sex and mild ABCA4 alleles among patients with Stargardt disease did not hold up upon reevaluation.

An overview of the latest news in Parkinson disease reported across MJH Life Sciences™.

In the June 5, 1981, issue of the Morbidity and Mortality Weekly Report from the CDC, a brief 3-page report appeared describing 5 rare cases of Pneumocystis carinii pneumonia among 5 homosexual men in Los Angeles. Our full Q&A with the lead author on that report, Michael Gottlieb, MD, will appear next week. Below is a video preview.

As working women have been disproportionately impacted by COVID-19, solutions to address what has been coined a “she-cession” include targeted communications, flexible work schedules, and increased education/tutoring resources.

Production will begin within weeks on the GlaxoSmithKline/Sanofi COVID-19 vaccine candidate; nearly 3 of every 4 people who had severe cases of COVID-19 experience at least one long-term symptom; US colleges and universities report stark rise in applications in the public health field.

Here are some of the latest developments in multiple sclerosis (MS) from our sister publication, NeurologyLive®.

Abstracts from the ATS 2021 International Conference addressed patient decision-making frameworks for seeking care for chronic obstructive pulmonary disease (COPD) and tactics used to assist hospitals in implementing readmission reduction plans.

A phase 3 trial explored which treatment option for pemphigus vulgaris, a rare skin disease, resulted in better outcomes after 52 weeks.

Methotrexate reduces cardiovascular risk in patients with inflammatory disease but not in the general population.

Researchers underscored the importance of addressing these barriers, as artificial intelligence may offer improvements in clinical decision making, broaden access to care, and improve clinical efficiency.

A review detailed the initial steps taken into personalized therapeutic options for psoriatic arthritis.

Sonia T. Oskouei, PharmD, BCMAS, DPLA, from Cardinal Health, explains the ramifications that interchangeability designations will have on biosimilars and when we might see the first interchangeable biosimilar in the United States.

A CDC report finds that the risk of COVID-19 infection among those fully vaccinated is 0.01%; HHS announce it is designating $4.8 billion to cover COVID-19 testing for uninsured US residents; European Union seeks significant fine for AstraZeneca over breach of vaccine supply contract.

Patients with acute myeloid leukemia (AML) who relapse after first-line treatment face a substantial health care resource utilization (HCRU) and cost burden, according to a poster presented at Virtual ISPOR 2021.

Analyses showed differential brain activity among migraineurs with anxiety compared with those without anxiety and healthy controls.

Recent coverage from Targeted Oncology® highlights how combination therapies are impacting the treatment spectrum for chronic lymphocytic leukemia (CLL).

Between 2014 and 2018, annual diagnoses for HIV in an emergency department (ED) in Hamilton County, Ohio, more than doubled, from 20 to 42.

Abstracts from the ATS 2021 International Conference provided some insight into tactics that could improve the effectiveness of pulmonary rehabilitation programs in patients with chronic obstructive pulmonary disease (COPD).

A new report shows work-related quality of life in general—and also in terms of physical and mental/emotional health—improved when patients began treatment for atopic dermatitis.

The new report, based on more than 80,000 health records, suggests positive airflow pressure therapy can reduce a patient’s risk of infection.

On this episode of Managed Care Cast, we speak with Gregory Harris, MD, MPH, DFAPA, senior medical director for behavioral health at Blue Cross Blue Shield of Massachusetts, about the challenges of meeting the demand for mental health service during the COVID-19 pandemic.

Michelle M Cloutier, MD, is professor emerita at UCONN Health in Farmington, Connecticut, and chair of the National Asthma Education and Prevention Program (NAEPP) Coordinating Committee Expert Panel Working Group.

Optogenics was used to partially restore a blind man’s eyesight; the FDA could soon approve Moderna’s COVID-19 vaccine for use among adolescents; HHS calls for a new investigation into COVID-19’s origins.

A recent analysis of The Environmental Determinants of Diabetes in the Young study found maternal diet has no impact on type 1 diabetes and islet autoimmunity (IA) risk.

Results from Sharecare's Community Well-Being Index show Massachusetts was the healthiest state in 2020 while Mississippi ranked last.